Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Kors van der Ent

CFTR Activity Is Enhanced by the Novel Corrector GLPG2222, Given With and Without Ivacaftor in Two Randomized Trials

Journal of Cystic Fibrosis

English

Rapid Increase of Blood Pressure After Low Dose Hydrocortison (HC) in Low Birth Weight Neonates With Hypotension Refractory to High Doses of Cardio-Inotropics 210

English

Related publications

Adaptive Pre-Specification in Randomized Trials With and Without Pair-Matching

Statistics in Medicine

English

Intensive Blood Pressure Lowering in Patients With and Patients Without Type 2 Diabetes: A Pooled Analysis From Two Randomized Trials

English

Low Free Drug Concentration Prevents Inhibition of F508del CFTR Functional Expression by the Potentiator VX-770 (Ivacaftor)

British Journal of Pharmacology

Pharmacology

2016

English

Group Homogeneity Is Paramount in Randomized Trials

Journal of Thoracic and Cardiovascular Surgery

Respiratory Medicine

Pulmonary

Cardiovascular Medicine

Surgery

Cardiology

2019

English

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for Ivacaftor Therapy in the Context of CFTR Genotype

Clinical Pharmacology and Therapeutics

Pharmacology

2014

English

Human PrimPol Activity Is Enhanced by RPA

Scientific Reports

Multidisciplinary

2017

English

Discovery of a Picomolar Potency Pharmacological Corrector of the Mutant CFTR Chloride Channel

Science advances

Multidisciplinary

2020

English

The Magnitude of Ivacaftor Effects on Fluid Secretion via R117h-CFTR Channels: Human in Vivo Measurements

PLoS ONE

Multidisciplinary

2017

English

Insulin Secretion Improves in Cystic Fibrosis Following Ivacaftor Correction of CFTR: A Small Pilot Study

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Kors van der Ent

CFTR Activity Is Enhanced by the Novel Corrector GLPG2222, Given With and Without Ivacaftor in Two Randomized Trials

Rapid Increase of Blood Pressure After Low Dose Hydrocortison (HC) in Low Birth Weight Neonates With Hypotension Refractory to High Doses of Cardio-Inotropics 210

Related publications

Adaptive Pre-Specification in Randomized Trials With and Without Pair-Matching

Intensive Blood Pressure Lowering in Patients With and Patients Without Type 2 Diabetes: A Pooled Analysis From Two Randomized Trials

Low Free Drug Concentration Prevents Inhibition of F508del CFTR Functional Expression by the Potentiator VX-770 (Ivacaftor)

Group Homogeneity Is Paramount in Randomized Trials

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for Ivacaftor Therapy in the Context of CFTR Genotype

Human PrimPol Activity Is Enhanced by RPA

Discovery of a Picomolar Potency Pharmacological Corrector of the Mutant CFTR Chloride Channel

The Magnitude of Ivacaftor Effects on Fluid Secretion via R117h-CFTR Channels: Human in Vivo Measurements

Insulin Secretion Improves in Cystic Fibrosis Following Ivacaftor Correction of CFTR: A Small Pilot Study